Search the Community

Frontiers in translational systemic sclerosis (SSc) research: a focus on the unmet 'cutaneous' clinical needs (Viewpoint). This viewpoint considers four cutaneous unmet clinical needs of patients with Ssc, which cause pain, disability, and/or disfigurement, all impact on quality of life, and for each we require effective treatments. PubMed, Exp Dermatol, 08/25/2020. (Also see Skin Involvement) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

Case Report: Efficacy and Metabolic Effect on Serum Lipids of Apremilast in Psoriatic Arthritis (PsA). Our observations suggest that apremilast is effective in controlling mild skin and joint involvement and suggest a potentially advantageous metabolic effect in patients with PsA. PubMed, J Clin Med, 2019 Mar 22;8(3). (Also see Psoriasis and Psoriatic Arthritis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.